Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery

Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery

Study designed to evaluate the safety and efficacy of double staining with brilliant blue G 0.025% as an adjuvant to macular surgery. Patients undergoing surgery for macular hole or epiretinal membrane will be included. Safety will be evaluated by optic coherence tomography, pattern reversal electroretinogram and multifocal electroretinogram.

Inclusion Criteria:

• Patient age 18 years of older
• Signing of informed consent
• Macular pathology requiring vitrectomy (epiretinal membrane, macular hole, vitreomacular traction syndrome)

Exclusion Criteria:

• Diagnosis of glaucoma
• Known allergy to brilliant blue G